Programme

The Probiota Asia programme provides an opportunity for business and academia to come together to discuss the challenges and opportunities of today’s evolving marketplace, finding new ways to translate scientific discoveries into pioneering products that today’s consumers want to buy.

Tuesday, 26 October, 2021

Scientific Breakthroughs: Cutting-Edge Microbiome Research Amid the Pandemic

This session has now aired and will be available on-demand shortly for registered delegates

We will kick off with a session on Scientific Breakthroughs: Cutting Edge Microbiome Research Amid the Pandemic with immunity, vaccines and COVID-19 at the forefront. This broadcast will feature two high-level presentations from Prof David Lynn, EMBL Australia Group Leader and Program Director, The SAHMRI Precision Medicine Theme, and Prof Siew C NG, Director of Microbiota (ICenter MagIC ) at Hong Kong Science and Technology Park and Associate Director of Centre for Gut Microbiota Research, The Chinese University of Hong Kong. Prof Lynn will be asking ‘Can the microbiota be targeted to enhance immune responses to vaccination?’, while Prof Ng will assess ‘The promise of Microbiota modulation during the COVID 19 pandemic’.

We’ll also have a live and interactive panel debate featuring a host of international experts, as well as extensive networking and group discussion opportunities.

View the agenda

Wednesday, 27 October, 2021

Probiotics and Beyond: From Personalisation to Artificial Intelligence

This session has now aired and will be available on-demand shortly for registered delegates

This broadcast will be detailing how the latest scientific and technological developments will propel the industry in the years to come, and will include expert insights from Evan Hayes, Managing Director Asia Pacific at Factors Group, and Agathe Foussat, Head of Digital Innovation at Danone. Evan will be assessing the opportunities for personalisation spanning probiotics, prebiotics, synbiotics and postbiotics, while Agathe will look at how the latest digital and data tools, including Ai and Big Data, can aid microbiome innovation.

We’ll also have a live and interactive panel debate featuring a host of international experts, as well as extensive networking and group discussion opportunities.

View the agenda

Tuesday, 2 November, 2021

Opportunity Asia and Middle East: Regulations and Market Access Decoded

This session has now aired and will be available on-demand shortly for registered delegates

This session will feature a raft of market experts from China, South Korea, South East Asia and the Middle East, all of whom will provide the very latest regulatory updates, market opportunities, and state-of-the industry assessments from their respective regions. This is a must-attend session for anyone exploring expansion in the region.

The broadcast will close with a live and interactive panel debate featuring a host of international experts, as well as extensive networking and group discussion opportunities.

View the agenda

Wednesday, 3 November, 2021

Idea to Commercialisation: Product Development, Innovation and Format Opportunities

This session has now aired and will be available on-demand shortly for registered delegates

The event will conclude with a deep dive into Idea to Commercialisation: Product Development, Innovation and Format Innovation, featuring the latest NPD opportunities from the biggest MNCs, to the region’s pioneering start-ups. This edition will feature a keynote talk from Dr Pietro Antonio Tataranni, MD Chief Medical Officer, Senior Vice President, Life Sciences at PepsiCo, as well as our Functional Foods Innovators session including start-ups from China, Australia and Singapore.

As ever, the broadcast will close with a live and interactive panel debate featuring a host of international experts, as well as extensive networking and group discussion opportunities.

View the agenda